United States· US:53489-478_2524fd49-5789-e388-e063-6394a90a2c9b
SULINDAC
A sulindac product containing sulindac, registered in United States by Sun Pharmaceutical Industries, Inc.. The same ATC class is registered in 6 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Sulindac is registered in 6 of 19 countries.
Countries holding a registration under ATC M01AB02 (sulindac), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Sulindac · ATC M01AB02
6 / 19 countries
- Canada
- Finlandprice
- Franceprice
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sulindac costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sulindac · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- FR France$0.48
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SULINDAC
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Country
- United States (US)
- ATC code
- M01AB02
- ATC class
- Sulindac
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 12
- ndc1153489-478-01
- ndc1153489-478-02
- ndc1153489-478-03
- ndc1153489-478-05
- ndc1153489-478-06
- ndc1153489-478-10
- ndc115348947801100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01)
- ndc11534894780250 TABLET in 1 BOTTLE, PLASTIC (53489-478-02)
- ndc115348947803250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03)
- ndc115348947805500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05)
- ndc11534894780660 TABLET in 1 BOTTLE, PLASTIC (53489-478-06)
- ndc1153489478101000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
249 interactions on record for sulindac.
Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sulindac · interactions on record
249 records
- 59 severe
- 142 moderate
- 5 minor
- 43 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sulindac in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaTEVA-SULINDACTEVA CANADA LIMITED
- United KingdomClinoril 100mg tabletsOrganon Pharma (UK) Ltd
- FranceARTHROCINE 100 mg, compriméMEDAC
- FinlandClinorilMerck Sharp & Dohme B.V.
- NorwayArthrocineMedac
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- France · Arthrocine
- United Kingdom (Northern Ireland) · Sulindac Chemidex Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ab5ea2f0-09b1-44ef-aa4a-8682262a68b8 GET /v1/drugs/ab5ea2f0-09b1-44ef-aa4a-8682262a68b8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "150",
"substance": "SULINDAC",
"productndc": "53489-478",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA072050",
"marketing_category": "ANDA"
}See everything about sulindac.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.